Fortbildung bei der DGRA e.V.
DGRA-Jahreskongress
Jahr 2008
17. - 18. Juni 2008 in Bonn
Moderation
Termine
Dienstag, 17. Juni 2008 | 09.30 Uhr bis 19.00 Uhr
Mittwoch, 18. Juni 2008 | 09.30 Uhr bis 14.00 Uhr Termin in den eigenen Kalender übertragen
Veranstaltungsort
Wasserwerk Bonn
Hermann-Ehlers-Straße Eingang V, 53113 Bonn
Tel.: +49 (0)228 / 92 67 - 0
Routenplaner
Download
-
Programmvorschau Änderungen vorbehalten
Programm am 17. Juni 2008
9.30 Welcoming Speech by Dr. Ulrich Granzer 9.45 Pharmaceuticals in the EU: Heading for the Future – "Have your Say" Initiative Initiative of the EU Commission: Public consultation on the future of pharmaceuticals for human use in the EU - Background and present state of play
Revising the pharmaceutical landscape in the EU – The industry ́s perspective
Christine-Lise Joulou, EFPIA, Brussels10.45 Coffee break 11.15 An Eu-Member State position Dr. Aginus Kalis, MEB, The Hague Transatlantic Simplification of Administrative Procedures in the Area of Pharmaceuticals
Arielle North, EMEA, London12.15 Panel Discussion 12.45 Lunch break 14.15 Heading for New Approaches – Future of the BfArM in the EU MA System Prof. Dr. Johannes Löwer, BfArM, Bonn Advanced Therapies: Implementing New Regulations - Products concerned
- Authorisation procedures
15.15 Coffee break 15.45 Consequences for research-based industry Dr. Gabriele Schäffner, NDA, Freiburg 16.15 Panel Discussion with all Speakers 16.40 One Year Pediatric Committee – PDCO - Main tasks
- Problems of ongoing PIP ́s
- Experience and outcome
17.00 Award of the Walter Cyran Medal (ends at around 17.30) 19.00 Pre-Dinner Speech: 10 Years DGRA – What Next? Dr. Ulrich Granzer, Chair of the DGRA
Reception and buffetProgramm am 18. Juni 2008
9.30 EU Variations Regulations - Revision of the EU Variations Regulations – outcome of the consultation process and further steps
- Consequences for the pharmaceutical industry – Will the changes make the EU a more competitive market place?
11.00 Coffee break 11.30 Consequences for competent authorities - Will the change simplify administrative hurdles? Dr. Truus Janse-de Hoog, MEB, The Hague EU Variation System binding for national MA? – Consequences for authorities Susanne Winterscheid, BfArM, Bonn 12.30 Panel Discussion with all Speakers 13.00 End 14.00 DGRA Members’ Meeting -
Kostenbeitrag und Stornierungen
For DGRA members: € 450,-
For non-members: € 590,-
Students special: Students of the DGRA courses (MDRA I to IX) and delegates of bodies who are members of the DGRA: € 240,-- Up to two weeks before the first day of the conference: € 50,-
- Up to one week before the first day of the conference: 50% of fee
- Later cancellations: full conference fee if a substitute participant (DGRA member) cannot be put forward.
In the event of cancellation by the organizer, any fees already paid will be fully reimbursed.
-
Anreise und Unterkunft
Hotel (Günnewig) Bristol
Prinz-Albert-Straße 2
D-53113 Bonn
Tel.: 0228/26 98-0
Fax: 0228/26 98-2 22
Hotel Hilton
Berliner Freiheit 2
D-53111 Bonn
Tel.: 0228/7269-0
Fax: 0228/7269-700
Hotel (Günnewig) Residence
Kaiserplatz 11
D-53113 Bonn
Tel.: 0228/2697-0
Fax: 0228/2697-777
Hotel Königshof
Adenauerallee 9
D-53111 Bonn
Tel.: 0228/26 01-0
Fax: 0228/26 01-529
Hotel Maritim
Godesberger Allee
D-53175 Bonn
Tel.: 0228/81 08-0
Fax: 0228/81 08-811
A limited number of rooms are available for participants at special rates in the hotels listed below. When making reservations please refer to this event. - Walter-Cyran-Medaille
-
Mitgliederversammlung Mitgliedern vorbehalten
-
Unterlagen
Vorträge am 17. Juni 2008
Pharmaceuticals in the EU: Heading for the Future
Martin Terberger, EU Commission, BrusselsRevising the Pharmaceutical Landscape in the EU
Christine-Lise Julou, EFPIA, BrusselsHeading for the Future: Convergence of medical products
Dr. Aginus Kalis, MEB, The HagueTransatlantic Simplification of Administrative Procedures in the Area of Pharmaceuticals
Arielle North, EMEA, LondonHeading for New Approaches - Future of the BfArM in the EU MA System
Prof. Dr. Johannes Löwer, BfArM, BonnAdvanced therapy medicinal products
Prof. Dr. Claus Cichutek, PEI, LangenAdvanced therapies: Implementing New Regulations - Consequences for research-based industry
Dr. Gabriele Dallmann (formerly Schäffner), NDA, FreiburgEU Paediatric Regulation - One Year PDCO
Prof. Daniel Brasseur, EMEA, LondonVorträge am 18. Juni 2008
Revision of the EU Variations Regulations - Outcome of the Consultation Procedure and Further Steps
Dr. Susanne Keitel, EDQM/DEQM, StrasbourgConsequences for the pharmaceutical industry - Will the changes make the EU a more competitive market place?
Dr. Rüdiger Faust, Grünenthal GmbH, AachenConsequences for competent authorities - Will the change simplify administrative hurdles?
Dr. Truus Janse-de Hoog, MEB, The HagueEU-Variation System binding for natioal MA?
Susanne Winterscheid, BfArM, Bonn